丹诺医药成立于2013年，是一家以临床需求为导向，专门从事差异化抗菌新药产品研发的生物制药公司。拥有一个独特的多靶点偶联分子抗菌新药研发平台和一个全球知识产权保护的抗菌新药产品研发管线，目标适应症包括医疗器械相关生物膜感染、肝硬化肝性脑病和幽门螺杆菌感染等适应症，以解决这些领域未满足临床需求，为中国乃至全球患者提供安全有效的治疗手段。
Location: China, Gansu, Suzhou
Member count: 11-50
Founded date: 2013
Investors 2
| Date | Name | Website |
| - | 6 Dimensio... | 6dimension... |
| - | Northern L... | nlvc.com |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 22.11.2021 | TenNor Rep... | SUZHOU, China, Nov. 22, 2021 /... | - | - | en.prnasia... |
| 19.09.2016 | TenNor The... | TenNor Therapeutics, a Suzhou,... | China | - | finsmes.co... |
| - | TenNor The... | “Danyo Pharmaceutical was esta... | - | - | fastfounde... |